Gil Arbel

6.2k total citations · 2 hit papers
31 papers, 4.6k citations indexed

About

Gil Arbel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gil Arbel has authored 31 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gil Arbel's work include Pluripotent Stem Cells Research (19 papers), Neuroscience and Neural Engineering (18 papers) and Cardiac electrophysiology and arrhythmias (11 papers). Gil Arbel is often cited by papers focused on Pluripotent Stem Cells Research (19 papers), Neuroscience and Neural Engineering (18 papers) and Cardiac electrophysiology and arrhythmias (11 papers). Gil Arbel collaborates with scholars based in Israel, United States and Germany. Gil Arbel's co-authors include Lior Gepstein, Amira Gepstein, Oren Caspi, Irit Huber, Ilanit Itzhaki, Izhak Kehat, Jonathan Satin, Leonid Maizels, Manhal Habib and Limor Zwi‐Dantsis and has published in prestigious journals such as Nature, Circulation and Nature Biotechnology.

In The Last Decade

Gil Arbel

30 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modelling the long QT syndrome with induced pluripotent stem cells

2011 765 citations Ilanit Itzhaki, Leonid Maizels et al. profile →
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells

2004 622 citations Izhak Kehat, Oren Caspi et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Gil Arbel

Since Specialization

Citations

This map shows the geographic impact of Gil Arbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Arbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Arbel more than expected).

Fields of papers citing papers by Gil Arbel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Arbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Arbel. The network helps show where Gil Arbel may publish in the future.

Co-authorship network of co-authors of Gil Arbel

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Arbel. A scholar is included among the top collaborators of Gil Arbel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Arbel. Gil Arbel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilizing Human-Induced Pluripotent Stem Cells to Study Cardiac Electroporation Pulsed-Field Ablation 2024 ·Circulation Arrhythmia and Electrophysiology ·Leonid Maizels, (unknown), (unknown), (unknown), Irit Huber, Gil Arbel, Amira Gepstein, Doron Aronson, Shirley Sharabi, Roy Beinart, Amit Segev, Elad Maor, Lior Gepstein	6
2	Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling 2022 ·Physiological Reports ·(unknown), Anke J. Tijsen, Leonid Maizels, Gil Arbel, Amira Gepstein, Nicola Bates, Benjamin Brown, Irit Huber, Susan J. Kimber, William G. Newman, Luigi Venetucci, Lior Gepstein	8
3	Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes 2021 ·JCI Insight ·Amit Gruber, (unknown), Irit Huber, Gil Arbel, Amira Gepstein, Assad Shiti, Naim Shaheen, (unknown), (unknown), Lior Gepstein	18
4	Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell–Derived Cardiac Cell Sheets 2019 ·Journal of the American College of Cardiology ·Rami Shinnawi, Naim Shaheen, Irit Huber, Assad Shiti, Gil Arbel, Amira Gepstein, Nimer Ballan, (unknown), Anke J. Tijsen, Martin Borggrefe, Lior Gepstein	64
5	Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications 2019 ·Acta Biomaterialia ·Idit Goldfracht, Yael Efraim, Rami Shinnawi, Ekaterina Kovalev, Irit Huber, Amira Gepstein, Gil Arbel, Naim Shaheen, Malte Tiburcy, Wolfram H. Zimmermann, Marcelle Machluf, Lior Gepstein	162
6	Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies 2018 ·Stem Cell Reports ·Naim Shaheen, Assad Shiti, Irit Huber, Rami Shinnawi, Gil Arbel, Amira Gepstein, (unknown), Idit Goldfracht, Amit Gruber, (unknown), Lior Gepstein	62
7	Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters 2015 ·Stem Cell Reports ·Rami Shinnawi, Irit Huber, Leonid Maizels, Naim Shaheen, Amira Gepstein, Gil Arbel, Anke J. Tijsen, Lior Gepstein	100
8	Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients 2012 ·European Heart Journal ·Limor Zwi‐Dantsis, Irit Huber, Manhal Habib, (unknown), Amira Gepstein, Gil Arbel, Lior Gepstein	64
9	Modeling of Catecholaminergic Polymorphic Ventricular Tachycardia With Patient-Specific Human-Induced Pluripotent Stem Cells 2012 ·Journal of the American College of Cardiology ·Ilanit Itzhaki, Leonid Maizels, Irit Huber, Amira Gepstein, Gil Arbel, Oren Caspi, Liron Miller, Bernard Belhassen, Eyal Nof, Michael Glikson, Lior Gepstein	162
10	Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes 2011 ·PLoS ONE ·Ilanit Itzhaki, S. Sh. Rapoport, Irit Huber, Itzhak Mizrahi, Limor Zwi‐Dantsis, Gil Arbel, Jackie Schiller, Lior Gepstein	148
11	A combined cell therapy and in-situ tissue-engineering approach for myocardial repair 2011 ·Biomaterials ·Manhal Habib, Keren Shapira‐Schweitzer, Oren Caspi, Amira Gepstein, Gil Arbel, Doron Aronson, Dror Seliktar, Lior Gepstein	63
12	Scalable Production of Cardiomyocytes Derived from c-Myc Free Induced Pluripotent Stem Cells 2010 ·Tissue Engineering Part A ·Limor Zwi‐Dantsis, Itzhak Mizrahi, Gil Arbel, Amira Gepstein, Lior Gepstein	16
13	Methods for Human Embryonic Stem Cells Derived Cardiomyocytes Cultivation, Genetic Manipulation, and Transplantation 2010 ·Methods in molecular biology ·Gil Arbel, Oren Caspi, Irit Huber, Amira Gepstein, Michal Weiler‐Sagie, Lior Gepstein	6
14	Transplantation of a Tissue-Engineered Human Vascularized Cardiac Muscle 2009 ·Tissue Engineering Part A ·Ayelet Lesman, Manhal Habib, Oren Caspi, Amira Gepstein, Gil Arbel, Shulamit Levenberg, Lior Gepstein	182
15	In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes 2008 ·Stem Cells and Development ·Oren Caspi, Ilanit Itzhaki, Izhak Kehat, Amira Gepstein, Gil Arbel, Irit Huber, Jonathan Satin, Lior Gepstein	177
16	Transplantation of Human Embryonic Stem Cell-Derived Cardiomyocytes Improves Myocardial Performance in Infarcted Rat Hearts 2007 ·Journal of the American College of Cardiology ·Oren Caspi, Irit Huber, Izhak Kehat, Manhal Habib, Gil Arbel, Amira Gepstein, Lior Yankelson, Doron Aronson, Rafael Beyar, Lior Gepstein	401
17	Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes 2004 ·The Journal of Physiology ·Jonathan Satin, Izhak Kehat, Oren Caspi, Irit Huber, Gil Arbel, Ilanit Itzhaki, János Magyar, Elizabeth A. Schroder, Ido Perlman, Lior Gepstein	220
18	Electromechanical integration of cardiomyocytes derived from human embryonic stem cells breakdown → 2004 ·Nature Biotechnology ·Izhak Kehat, (unknown), Oren Caspi, Amira Gepstein, Rona Shofti, Gil Arbel, Irit Huber, Jonathan Satin, Joseph Itskovitz‐Eldor, Lior Gepstein	622
19	Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint 2003 ·Histochemistry and Cell Biology ·Amira Gepstein, Gil Arbel, Israel Blumenfeld, Micha Peled, Erella Livne	27
20	Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging 2002 ·Arthritis & Rheumatism ·Amira Gepstein, Sarah Shapiro, Gil Arbel, Nitza Lahat, Erella Livne	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact